The ProGen SNMMI 2026 Field Guide
A commercial intelligence report for operators and investors attending the Society of Nuclear Medicine and Molecular Imaging Annual Meeting.
30 May to 02 June 2026 · Los Angeles Convention Center · 70 pages · Published 12 May 2026
Single-user: one named reader. Corporate: unlimited internal distribution at one company.
The ProGen SNMMI 2026 Field Guide is an independent publication and is not affiliated with, sponsored by, or endorsed by the Society of Nuclear Medicine and Molecular Imaging.
Who this is for
Business development leads. Senior executives. Investors. Bankers. Recruiters. Journalists. The audience already knows what theranostics is, what PSMA targets, and the difference between alpha and beta therapy. The guide does not re-explain any of it.
This guide is not for clinicians looking for an educational primer, students researching the field, or readers seeking a balanced and polite vendor catalogue. Where a company is coasting, behind, or carrying an unresolved issue, the text says so with sources.
What’s inside
01
The Capacity-Over-Chemistry Thesis
Why infrastructure has overtaken chemistry as the binding constraint.
02
The Twenty BD Booths That Matter Most
Ranked by BD utility, not market cap.
03
The Ten Investor Booths
Ranked by live investor catalysts inside 12 months.
04
Five Sessions Not To Miss
Where the operating economics of radiopharma get decided in public.
05
Three Contrarian Observations
Each one changes a BD or investment position if correct.
06
The Ac-225 Capacity Map
Producers, consumers, locked vs exposed.
07
Lu-177, Pb-212, Cu-67 and the Adjacent Supply Picture
Every isotope that matters commercially in 2026.
08
The Geopolitical Layer
China critical minerals, Russian reactor dependency, US domestic push, European production.
09
Who Will Be On The Ground
Confirmed senior attendees and recently-moved executives.
10
Side Events, Dinners and the LA Hotel Map
Where the unbadged conversations happen.
11
The 90-Day Catalysts Watchlist
Twelve dated events that extend the guide’s shelf life past LA.
12
Anomalies and Red Flags
Six places where the public surface and underlying reality have drifted apart.
13
Pressure Points
Four programmes likely to be re-rated in the 90 days after SNMMI.
Plus
Appendix A
Tiered exhibitor directory
All 250 SNMMI 2026 exhibitors.
Appendix B
About ProGen Search
Firm overview and methodology notes.
Appendix C
Other intelligence from ProGen Search
Adjacent reports and sector briefs.
A sample of what’s inside
Six anchor data points from the guide.
01
Cardinal Health quadrupled weekly Ac-225 output at the Indianapolis CTA since late 2024.
02
BWXT closed Kinectrics on 20 May 2025 for approximately USD 525 million, picking up the Isogen Ac-225 JV stake.
03
ITM COMPETE Phase 3: median PFS 23.9 vs 14.1 months versus everolimus (HR 0.67, p=0.022). NDA accepted by FDA.
04
Aktis Oncology priced 17.65 million shares at USD 18.00 on 8 January 2026 for USD 317.7 million gross proceeds.
05
Telix Regeneron collaboration signed 13 April 2026: USD 40 million upfront, up to USD 2.1 billion total.
06
SHINE Technologies received a DOE conditional commitment of up to USD 263 million on 9 April 2026 for the Chrysalis Mo-99 buildout.
Methodology
Research window: 11 April to 11 May 2026. Every numeric claim, dated event, and personnel statement carries a source URL. Sources: primary exhibitor pages, regulatory filings, financial disclosures, press releases, scientific abstracts, and named-source reporting. The full methodology is in Appendix B of the guide.
About ProGen Search
ProGen Search Limited is a specialist executive search and commercial intelligence firm for the life sciences industry. Byron Fitzgerald is the founder. The firm works with radiopharmaceutical companies, antibody-drug conjugate developers, cell and gene therapy operators, CDMOs, CROs, and the wider biotech ecosystem on senior commercial, technical, and operational hires.
The intelligence side of the firm produces standalone reports for paid distribution, a bi-weekly newsletter, and bespoke briefings for clients on retained searches.
The ProGen SNMMI 2026 Field Guide
70 pages. Published 12 May 2026.
Single-user: one named reader. Corporate: unlimited internal distribution at one company.
Publisher
ProGen Search Limited · Ground Floor, Techno Centre, Station Road, Horsforth, Leeds, LS18 5BJ · Company number 16067139
The ProGen SNMMI 2026 Field Guide is an independent publication and is not affiliated with, sponsored by, or endorsed by the Society of Nuclear Medicine and Molecular Imaging.